Cargando…
Inhibition of Grb14, a negative modulator of insulin signaling, improves glucose homeostasis without causing cardiac dysfunction
Insulin resistance increases patients’ risk of developing type 2 diabetes (T2D), non-alcoholic steatohepatitis (NASH) and a host of other comorbidities including cardiovascular disease and cancer. At the molecular level, insulin exerts its function through the insulin receptor (IR), a transmembrane...
Autores principales: | Ding, Xunshan, Iyer, Rugmani, Novotny, Christopher, Metzger, Daniel, Zhou, Heather H., Smith, Gordon I., Yoshino, Mihoko, Yoshino, Jun, Klein, Samuel, Swaminath, Gayathri, Talukdar, Saswata, Zhou, Yingjiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7042267/ https://www.ncbi.nlm.nih.gov/pubmed/32099031 http://dx.doi.org/10.1038/s41598-020-60290-1 |
Ejemplares similares
-
PF-05231023, a long-acting FGF21 analogue, decreases body weight by reduction of food intake in non-human primates
por: Thompson, W. Clayton, et al.
Publicado: (2016) -
Identification of insulin-sensitizing molecules acting by disrupting the interaction between the Insulin Receptor and Grb14
por: Gondoin, Anaïs, et al.
Publicado: (2017) -
β Cell function and plasma insulin clearance in people with obesity and different glycemic status
por: Mittendorfer, Bettina, et al.
Publicado: (2022) -
Structural and functional studies of the Ras-associating and pleckstrin-homology domains of Grb10 and Grb14
por: Depetris, Rafael S, et al.
Publicado: (2009) -
Tyrosine phosphorylation of Grb14 by Tie2
por: Sturk, Celina, et al.
Publicado: (2010)